日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The impact of various forms of non-alcoholic beverage taxation on sales of non-alcoholic beverages and sugar in the Netherlands: a modelling study

荷兰各种形式的非酒精饮料税对非酒精饮料和糖销售的影响：一项建模研究

期刊:BMC Public Health
影响因子:3.6
doi:10.1186/s12889-025-25257-9
Eykelenboom, Michelle; Oosterhoff, Marije; Milder, Ivon E J; van Giessen, Anoukh
发表日期：2025
文献求助 收藏

Modelling alcohol consumption patterns to enable policy impact assessment

建立酒精消费模式模型以评估政策影响

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0327264
Ten Dam, Jasper; Rodenburg, A Jeroen; Koffijberg, Hendrik; Feenstra, Talitha L; van Giessen, Anoukh
发表日期：2025
文献求助 收藏

Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes

基于数据驱动的2型糖尿病亚组临床特征、并发症和治疗选择轨迹

期刊:Diabetologia
影响因子:10.2
doi:10.1007/s00125-024-06147-y
Li, Xinyu; Donnelly, Louise A; Slieker, Roderick C; Beulens, Joline W J; 't Hart, Leen M; Elders, Petra J M; Pearson, Ewan R; van Giessen, Anoukh; Leal, Jose; Feenstra, Talitha
糖尿病
代谢
发表日期：2024
文献求助 收藏

A Blueprint for Multi-use Disease Modeling in Health Economics: Results from Two Expert-Panel Consultations

卫生经济学中多用途疾病模型的蓝图：两次专家小组咨询的结果

期刊:Pharmacoeconomics
影响因子:4.6
doi:10.1007/s40273-024-01376-w
Wang, Junfeng; Pouwels, Xavier; Ramaekers, Bram; Frederix, Geert; van Lieshout, Chris; Hoogenveen, Rudolf; Li, Xinyu; de Wit, G Ardine; Joore, Manuela; Koffijberg, Hendrik; van Giessen, Anoukh; Knies, Saskia; Feenstra, Talitha
发表日期：2024
文献求助 收藏

Estimating the health impact of delayed elective care during the COVID -19 pandemic in the Netherlands

评估新冠疫情期间荷兰择期手术延误对健康的影响

期刊:Social Science & Medicine
影响因子:5
doi:10.1016/j.socscimed.2023.115658
Oosterhoff, Marije; Kouwenberg, Lisanne H J A; Rotteveel, Adriënne H; van Vliet, Ella D; Stadhouders, Niek; de Wit, G Ardine; van Giessen, Anoukh
微生物学
新冠
发表日期：2023
文献求助 收藏

Cost-Effectiveness of SGLT2 Inhibitors in a Real-World Population: A MICADO Model-Based Analysis Using Routine Data from a GP Registry

SGLT2抑制剂在真实世界人群中的成本效益：基于MICADO模型和全科医生注册中心常规数据的分析

期刊:Pharmacoeconomics
影响因子:4.6
doi:10.1007/s40273-023-01286-3
Li, Xinyu; Hoogenveen, Rudolf; El Alili, Mohamed; Knies, Saskia; Wang, Junfeng; Beulens, Joline W J; Elders, Petra J M; Nijpels, Giel; van Giessen, Anoukh; Feenstra, Talitha L
SGLT2
发表日期：2023
文献求助 收藏

Prediction of complications in health economic models of type 2 diabetes: a review of methods used

2型糖尿病卫生经济模型中并发症的预测：方法综述

期刊:Acta Diabetologica
影响因子:2.9
doi:10.1007/s00592-023-02045-8
Li, Xinyu; Li, Fang; Wang, Junfeng; van Giessen, Anoukh; Feenstra, Talitha L
糖尿病
代谢
发表日期：2023
文献求助 收藏

Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

伊克珠单抗治疗中重度斑块状银屑病：NICE单一技术评估的证据审查小组观点

期刊:Pharmacoeconomics
影响因子:4.6
doi:10.1007/s40273-018-0629-2
Ramaekers, Bram L T; Wolff, Robert F; Pouwels, Xavier; Oosterhoff, Marije; Van Giessen, Anoukh; Worthy, Gill; Noake, Caro; Armstrong, Nigel; Kleijnen, Jos; Joore, Manuela A
银屑病
发表日期：2018
文献求助 收藏

Ticagrelor for Secondary Prevention of Atherothrombotic Events After Myocardial Infarction: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

替格瑞洛用于心肌梗死后动脉粥样硬化血栓事件的二级预防：NICE单一技术评估的证据审查小组观点

期刊:Pharmacoeconomics
影响因子:4.6
doi:10.1007/s40273-017-0607-0
Pouwels, Xavier G L V; Wolff, Robert; Ramaekers, Bram L T; Van Giessen, Anoukh; Lang, Shona; Ryder, Steve; Worthy, Gill; Duffy, Steven; Armstrong, Nigel; Kleijnen, Jos; Joore, Manuela A
心血管
动脉粥样硬化
心肌梗塞
发表日期：2018
文献求助 收藏

Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes

筛查策略在检测2型糖尿病患者心力衰竭方面的成本效益分析

期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-016-0363-z
van Giessen, Anoukh; Boonman-de Winter, Leandra J M; Rutten, Frans H; Cramer, Maarten J; Landman, Marcel J; Liem, Anho H; Hoes, Arno W; Koffijberg, Hendrik
糖尿病
心力衰竭
心血管
代谢
发表日期：2016
文献求助 收藏